ESP.AS
Price:
$0.0092
Market Cap:
$0
Esperite N.V., together with its subsidiaries, operates as a regenerative and predictive medicine company in the Netherlands, Spain, Italy, Switzerland, and internationally. It operates through four segments: Stem Cell, The Cell Factory, Genoma, and Other. The company collects, processes, and stores human adult stem cells from the umbilical cord blood and the umbilical cord. It also provides proteomics and genomics predictive medicines; and implements its proprietary technology for clinical grade production of autologous mesenchymal and stromal stem cells. In addition, it develops AGAATA, a diagnostic system based on the next generation sequencing technology, as well as allows laboratories t...[Read more]
Industry
Medical - Care Facilities
IPO Date
2009-10-01
Stock Exchange
EURONEXT
Ticker
ESP.AS
According to Esperite N.V.’s latest financial reports and current stock price. The company's current ROE is 264.49%. This represents a change of -1281.67% compared to the average of -22.38% of the last 4 quarters.
The mean historical ROE of Esperite N.V. over the last ten years is -105.04%. The current 264.49% ROE has changed -351.80% with respect to the historical average. Over the past ten years (40 quarters), ESP.AS's ROE was at its highest in in the December 2009 quarter at 1.46%. The ROE was at its lowest in in the December 2016 quarter at -46.42%.
Average
-105.04%
Median
-18.32%
Minimum
-920.21%
Maximum
120.20%
Discovering the peaks and valleys of Esperite N.V. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 647.88%
Maximum Annual ROE = 120.20%
Minimum Annual Increase = -1267.47%
Minimum Annual ROE = -920.21%
Year | ROE | Change |
---|---|---|
2018 | 120.20% | -113.06% |
2017 | -920.21% | 647.88% |
2016 | -123.04% | 162.75% |
2015 | -46.83% | 99.09% |
2014 | -23.52% | 79.24% |
2013 | -13.12% | -77.11% |
2012 | -57.33% | -1267.47% |
2011 | 4.91% | -10.05% |
2010 | 5.46% | 76.91% |
2009 | 3.09% | -48.26% |
The current ROE of Esperite N.V. (ESP.AS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-307.69%
5-year avg
-198.68%
10-year avg
-105.04%
Esperite N.V.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Esperite N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Esperite N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Esperite N.V.'s ROE?
How is the ROE calculated for Esperite N.V. (ESP.AS)?
What is the highest ROE for Esperite N.V. (ESP.AS)?
What is the 3-year average ROE for Esperite N.V. (ESP.AS)?
What is the 5-year average ROE for Esperite N.V. (ESP.AS)?
How does the current ROE for Esperite N.V. (ESP.AS) compare to its historical average?